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STUDIES OF HYPOXEMIC/ 
REOXYGENATION INJURY: 
WITHOUT AORTIC 
CLAMPING 
IX. Importance of avoiding 
perioperative hyperoxemia 
in the setting of previous 
cyanosis 
This study of an in vivo infantile piglet model of compensated hypoxemia tests 
the hypothesis that reoxygenation on hyperoxemic cardiopulmonary b pass 
produces oxygen-mediated myocardial injury that can be limited by normox- 
emic management of cardiopulmonary b pass and the interval after cardio- 
pulmonary bypass. Twenty-five immature piglets (<3 weeks old) were placed 
on 120 minutes of eardiopulmonary b pass and five piglets served as a 
biochemical control group without cardiopulmonary bypass. Five piglets 
underwent cardiopulmonary bypass without hypoxemia (cardiopulmonary 
bypass control). Twenty others became hypoxemic on cardiopulmonary b pass 
for 60 minutes by lowering oxygen tension to about 25 mm Hg. The study was 
terminated in five piglets at the end of hypoxemia, whereas 15 others were 
reoxygenated at an oxygen tension about 400 mm Hg or about 100 mm Hg for 
60 minutes. Oxygen delivery was maintained uring hypoxemia by increasing 
eardiopulmonary b pass flow and hematocrit level to avoid metabolic acidosis 
and lactate production. Myocardial function after cardiopulmonary b pass 
was evaluated from end-systolic elastance (conductance atheter) and Starling 
curve analysis. Myocardial conjugated iene production and creatine kinase 
leakage were assessed as biochemical markers of injury, and antioxidant 
reserve capacity was determined by measuring malondialdehyde after cardio- 
pulmonary bypass in myocardium incubated in the oxidant, t-butylhydroper- 
oxide. Cardiopulnmnary bypass without hypoxemia caused no oxidant or 
functional damage. Conversely, reoxygenation at an oxygen tension about 400 
mm Hg raised myocardial conjugated iene level and creatine kinase produc- 
tion (CD: 3.5 -+ 0.7 A233 nm/min/100 g,creatine kinase: 8.5 _ 1.5 U/min/100 g, 
p < 0.05 vs cardiopulmonary b pass control), reduced antioxidant reserve 
capacity (malondialdehyde: 1115 - 60 nmol/g protein at 4.0 mmol t-butylhy- 
droperoxide, p < 0.05 vs control), and produced severe postbypass dysfunction 
(end-systolic elastance recovered only 39% - 7%,p < 0.05 vs cardiopulmonary 
bypass control). Lowering oxygen tension to about 100 mm Hg during 
reoxygenation avoided conjugated iene production and creatine kinase re- 
lease, retained normal antioxidant reserve, and improved functional recovery 
(80% - 11%, p < 0.05 vs oxygen tension about 400 mm Hg). These findings 
show that conventional hyperoxemic cardiopulmonary b pass causes unin- 
tended reoxygenation injury in hypoxemic mmature hearts that may contrib- 
ute to myocardial dysfunction after cardiopulmonary b pass and that normox- 
emic management may be used to surgical advantage. (J THORAC CARD1OVASC 
SURG 1995;110:1235-44) 
Kiyozo Morita, MD, a Kai Ihnken, MD, a Gerald D. Buckberg, MD," 
Michael P. Sherman, MD, b and Helen H. Young, PhD, a Los Angeles, Calif. 
C hronic cyanosis results in metabolic adaptations that maintain normal aerobic metabolism de- 
spite severe hypoxemia. 1' 2 Simultaneously, the cya- 
notic myocardium become depleted of endogenous 
antioxidants 3 and thereby more vulnerable to oxi- 
dant stress when cardiopulmonary bypass (CPB) is 
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initiated in cyanotic patients at hyperoxemic oxygen 
tension (P02) levels (i.e., about 400 mm Hg); we 
have speculated this causes oxygen-mediated myo- 
cardial injury, which intensifies intraoperative isch- 
emic damage and accentuates post-CPB myocardial 
dysfunction. 4 This hypothesis supported by clinical 
reports showing cardiac lipid peroxidation i  preis- 
chemic biopsy samples, 5 inadequate cardioplegic 
protection in cyanotic patients, 6 and myocardial 
dysfunction in infants placed on extracorporeal 
membrane oxygenation despite the absence of sur- 
gical ischemia. 7 
We have demonstrated previously in immature 
piglets that reoxygenation after acute hypoxemia 
induced by lowering inspired oxygen fraction 
(Fi02) by ventilator causes myocardial damage, 
which is associated with lipid peroxidation. 8 We 
have shown also that more gradual reoxygenation 
to hyperoxemic levels does not avoid this injury. 9 
Our prior studies have somewhat uncertain clini- 
cal relevance, because acute ventilator hypoxemia 
simulates acute asphyxia, which is not associated 
with the metabolic adaptations to chronic cyanosis 
(i.e., including polycythemia, augmented cardiac 
output, or both) and is usually characterized by 
hemodynamic deterioration and metabolic acido- 
sis, which decreases oxygen delivery and superim- 
poses ischemia. Experimental studies of chronic 
cyanosis confirm the increased susceptibility of 
cyanotic myocardium to ischemia/reperfusion in- 
jury10, 11 but are few in number because of high 
perioperative mortality and are limited by (1) an 
inability to produce a fixed Po 2 level and (2) the 
potential confounding hemodynamic conse- 
quences of cardiac pressure and volume overload- 
ing that makes changes caused by hypoxemia per 
se difficult to distinguish. 12 
This report describes an in vivo infantile piglet 
model of hypoxemia that is produced on CPB, 
whereby hematocrit level and perfusion rate are 
increased to ensure normal oxygen delivery and 
avoid anaerobic metabolism to simulate some of the 
metabolic adaptations occurring in cyanotic pa- 
tients. This model of compensated hypoxemia was 
used to test the hypotheses that (1) sudden reoxy- 
genation and hyperoxemic bypass produce oxygen- 
mediated injury after only a brief period of hypox- 
emia and (2) this oxygen-mediated damage can be 
limited by maintaining normoxemia during both 
CPB and after extracorporeal circulation is discon- 
tinued. 
Material and methods 
Experimental model. Twenty-five immature, 2- to 
3-week-old Yorkshire-Duroc piglets (3 to 5 kg) were 
premedicated with 0.5 mg/kg diazepam intramuscularly, 
anesthetized with 30 mg/kg pentobarbital intraperitone- 
ally followed by 5 mg/kg intravenously each hour, and the 
lungs ventilated on a volume-limited respirator (Servo 
900D, Siemens-Elema, Solna, Sweden) via a tracheos- 
tomy. All animals received humane care in compliance 
with the "Principles of Laboratory Animal Care" formu- 
lated by the National Society for Medical Research and 
the "Guide for the Care and Use of Laboratory Animals" 
prepared by the National Academy of Sciences, published 
by the National Institutes of Health (NIH Publication No. 
86-23, revised 1985). 
Physiologic and biochemical determinations 
Acid-base and blood gas analyses. Systemic arterial and 
venous blood gas, electrolyte, and hemoglobin measure- 
ments were made every 15 minutes during CPB (Blood 
Gas system 288, CIBA-Corning, Medfield, Mass.). Body 
oxygen delivery and uptake were calculated by the follow- 
ing equations: 
Oxygen delivery (Do2, ml/min/kg) = 
F × Caojbody weight (kg) 
Oxygen utilization (V02 ml/min/kg) = F × (Ca02 
- Cvo2)/body weight (kg) 
where F is pump flow (ml/min), Ca02 is oxygen content in 
arterial blood, and Cv02 is oxygen content in systemic 
venous blood. Cardiac output was determined by dupli- 
cate injections of i ml of 4 ° C saline solution into a central 
venous catheter. Cardiac index (CI), systemic vascular 
resistance index (SVRI), and left ventricular (LV) stroke 
work index (LVSWI) were calculated with the following 
equations: 
CI (ml/min/kg) = CO/body weight (kg) 
SVRI (mm Hg • min • L-  1 , kg) = (MAP - CVP) 
(mm Hg) • CO - 1 (L/min) • BW (kg) 
LVSWI (g • m/kg) = (MAP - LAP) × CO (ml/min) 
× 0.0136/(HR × body weight [kg]) 
where MAP is mean aortic pressure, LAP is mean left 
atrial pressure, CVP is central venous pressure, HR is 
heart rate (beats/min), and CO is cardiac output mea- 
sured by thermodilution method or CPB pump flow rate 
in milliliters per minute. 
Myocardial performance. LV pressure and conduc- 
tance catheter signals were amplified and digitalized to 
inscribe LV pressure-volume loops. After the procedure 
for correction of parallel conductance, a series of pres- 
sure-volume loops under variable loading conditions was 
generated by rapid transient occlusion of the inferior vena 
cava during a 7-second period of apnea, at a control 
condition, and 30 minutes after CPB was discontinued. 13 
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Fig. 1. Postbypass LV contraCtility. LV Ees after discontinuation of CPB, expressed as percent of 
individual prehypoxemic values. CPB: Piglets performed hyperoxemic bypass without hypoxemia; reoxy- 
genation: piglets subjected to hypoxemia/reoxygenation on CPB at Po 2 about 400 mm Hg or Po 2 about 100 
mm Hg. *p < 0.05 vs CPB; tp < 0.05 vs Po 2 about 400 mm Hg. 
The end-systolic pressure volume relationship 
(ESPVR) was analyzed by an interactive videographics 
data analysis computer program (Spectrum, Bowman 
Gray School of Medicine, Winston-Salem, N.C,) on an 
386/33 MHz IBM computer (IBM, Armonk, N.Y.), and 
LV performance was described as the slope of linear 
regression (end-systolic elastance [Ees]), as described 
previously. 14 Postbypass LV contractility was assessed by 
percent recovery of prebypass control value (percent Ees). 
LV performance before and after CPB was also evalu- 
ated by infusing blood from the CPB circuit at 5 ml/min/kg 
over a 3-minute period while recording CO, MAP, and 
LAP to inscribe Starling function curves. 
Myocardial oxidant injury 
Myocardial conjugated iene and creatine kinase produc- 
tion. For blood biochemical assessments, the aorta was 
clamped temporarily (1 to 2 minutes) while the proximal 
aorta was perfused with blood via a calibrated pump to 
keep the aortic root pressure 50 to 60 mm Hg. Blood 
samples were withdrawn from the proximal aorta and the 
coronary effluent (coronary sinus blood) and analyzed for 
conjugated ienes and creatine kinase (CK) (see below). 
These analyses were made during control (normoxemia), 
hypoxemia, and 5, 30, and 60 minutes of reoxygenation 
period. Blood samples were centrifuged immediately for 5 
minutes at 1000g, plasma was then stored in liquid nitro- 
gen, and hydroxy conjugated diene levels were determined 
as described by Lesnefsky and coworkers. 15 The plasma 
concentration of CK was measured by the method of 
OliverJ 6 Myocardial production of conjugated dienes and 
CK was calculated by the following equation: Myocardial 
production = (Ccs - Ca) × CBF/heart weight (100 gm) 
where Ccs and Ca are concentration i  coronary sinus and 
arterial blood sample corrected by hematocrit (per milli- 
liter of blood) and CBF (coronary blood flow, ml/min) is 
a flow rate via a calibrated pump into the proximal aorta 
during temporary aortic clamping. 
Antioxidant reserve capacity. The myocardial endoge- 
nous antioxidant state was assessed by determining in 
vitro lipid peroxidation i LV subendocardial muscle after 
completion of each experiment by the method of Godin 
and colleagues 17as previously described. 
Experimental groups 
Nonhypoxemic studies. Five piglets underwent 2 hours 
of CPB at about 400 mm Hg Po 2 without hypoxemia. 
Perfusion flow rate averaged about 100 ml/min/kg at 50 to 
60 mm Hg mean arterial pressure. 
Hypoxemia On CPB studies. Twenty piglets were placed 
on CPB, and arterial Po2 was reduced to approximately 25
mm Hg for 60 minutes by changing the blend of 0 2 and N 2 
in the oxygenator, as previously describedJ s 
HYPOXEMIA WITHOUT REOXYGENATION. In five piglets 
the experiment was terminated after 60 minutes of hypox- 
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Fig. 2. LV performance by volume infusion before hypoxemia (control: open circles), after reoxygenation 
at normoxemic P02 (P02 about 100 mm Hg: open squares), and at hyperoxemic P02 (P02 about 400 mm Hg: 
closed circles). Function curves are different (p < 0.05) at all LAP > 15 mm Hg. LVSWI, Left ventricular 
stroke work index. 
Table. Physiologic profile during hypoxemia versus 
normoxemia on CPB 
P 
Normoxemia Hypoxemia values* 
pH 7.48 _+ 0.02 7.41 ± 0.01 NS 
Pao2 (mm Hg) 126.5 -+ 14 24.0 ± 0.67 <0.01 
Paco2 (ram Hg) 25.1 + 2.0 29.3 _+ 1.5 NS 
BE (V-A) 1.55 _+ 1.35 1.83 _+ 0.45 NS 
Hct (%) 31.5 _+ 0.9 45.5 ± 1.4 <0.01 
PFI (ml/min/kg) 109 -+ 6 129.5 _+ 5.9 0.0126 
02 delivery (cc/min/kg) 13.0 ± 0.34 13.4 _+ 0.89 NS 
Vo 2 (cc/min/kg) 7.4 _+ 0.9 8.5 -+ 0.5 NS 
Lactate xtraction 1271 +- 510 1223 ± 712 NS 
Pa02, Arterial P02; Paco 2, arterial Pc02; BE, base excess; V,, venous; A, 
arterial; Hct, hematocrit; PFI, pump flow index; V02, 02 uptake. 
*Paired t test. 
emic perfusion to obtain cardiac biopsy specimens to 
quantify the effects of hypoxemia without subsequent 
reoxygenation. 
HYPOXEMIA/REOXYGENATION. In fifteen other piglets 
this 60 minutes hypoxemic interval was followed by 60 
minutes of reoxygenation  CPB. 
1. Normoxemic reoxygenation (Po2 about 100 mm Hg): 
in six piglets Po2 is raised to normoxemic levels (about 
100 mm Hg) and kept at this level during the 30-minute 
observation period after CPB. 
2. Hyperoxemic reoxygenation (Po 2 about 400 mm Hg): 
in nine piglets Po2 was raised to hyperoxemic levels 
(about 400 mm Hg) during CPB, and post-CPB venti- 
lation was with 100% oxygen to maintain hyperoxemia 
throughout the entire study interval. 
Statistics. Data were analyzed with the use of the 
StatView V2.0 program (Abacus Concepts Inc., Berkeley, 
Calif.) on a Macintosh Ilci computer (Apple, Inc., Cuper- 
tino, Calif.). Analysis of variance was used for intergroup 
comparison, and the paired Student test was used for 
comparison of variables within experimental groups. Dif- 
ferences were considered significant at the probability 
level ofp < 0.05. Group data were expressed as mean plus 
or minus standard error of the mean. 
Results 
2 
Hemodynamic results. Systemic (CPB) flow aver- 
aged 100 ml/min/kg at a mean arterial b lood pres- 
sure of about 60 mm Hg in control  studies. Systemic 
oxygen delivery (Do2) was 13 +_ 0.03 ml/min/kg, and 
pH remained about 7.4 without evidence of either 
cardiac or systemic lactate production. Comparable  
body oxygen delivery (Do2) was also achieved dur- 
ing hypoxemia by increasing CPB flow 30% and 
raising hematocr i t  level to 45%; pH remained ap- 
proximately 7.4, and no evidence of systemic or 
myocardial  lactate product ion occurred (Table). Hy- 
poxemia on CPB caused systemic vasodi lat ion in all 
experiments as SVRI  fell 62% _+ 10%. SVRI  re- 
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Fig. 3. Myocardial lactate production/extraction during hypoxemia-reoxygenation on CPB. CPB: Piglets 
performed hyperoxemic bypass without hypoxemia; reoxygenation: piglets performed reoxygenation  
CPB at Po2 about 400 mm Hg or about 100 mm Hg after hypoxemia. *p < 0.05 vs CPB; tp < 0.05 vs Po2 
about 400 mm Hg. 
turned to control levels during reoxygenation and 
remained normal during the post-CPB observation 
interval. 
LV contractility. In control studies, LV elastance 
(Ees) was unchanged after 2 hours of hyperoxemic 
cardiopulmonary b pass without superimposed hy- 
poxemia (Fig. 1, 102% _+ 9% recovery). Conversely, 
hyperoxemic reoxygenation was associated with only 
39% _+ 7% recovery of Ees (p < 0.05 vs control). 
Maintaining normoxemia (Po2 about 100 mm Hg) 
throughout the reoxygenation i terval restored LV 
contractility to 80% _+ 11% of pre-CPB levels (p < 
0.05 vs hyperoxemia, Fig. 1). A parallel depression 
of myocardial performance occurred when func- 
tional reserve capacity was tested by volume infu- 
sion (Starling curv e analysis) as piglets undergoing 
hyperoxemic reoxygenation recovered only 38% _+ 
9% of LVSWI at LAP 12 mm Hg, whereas LVSWI 
recovered 64% _+ 14% at comparable LAP when 
Po 2 was kept normoxemic during reoxygenation on 
bypass and during the post-CPB observation period 
(Fig. 2). 
Biochemistry results 
Myocardial lactate metabolism. Lactate was con- 
sumed by the myocardium throughout the i20 min- 
utes of hyperoxemic CPB in control studies when 
hypoxemia was not imposed. Comparable lactate 
consumption occurred uring hypoxemia (Table and 
Fig. 3), but lactate production was observed after 30 
minutes of hyperoxemic reoxygenation. Conversely, 
the myocardium continued to consume lactate when 
reoxygenation was conducted at Po2 100 mm Hg. 
Myocardial conjugated ienes. There was no con- 
jugated diene production in piglets undergoing 120 
minutes of CPB without hypoxemia (Fig. 4). Hyper- 
oxemic reoxygenation raised conjugated iene pro- 
duction 210% above resting levels at 60 minutes of 
reoxygenation (3.45 _+ 0.7, A233 nm min/100 g, p < 
0.05 vs CPB control), whereas negligible conjugated 
diene production occurred after normoxemic reoxy- 
genation (Fig. 4). 
CK release. No myocardial CK release occurred 
in piglets placed on CPB without hypoxemia (Fig. 
5). Hyperoxemic reoxygenation caused progress of 
CK release and reached 330% above prehyp0x- 
emic values 60 minutes after reoxygenation (8.5 _+ 
1.5 U/min/100 g, p < 0.05 vs CPB control). In 
contrast, CK production was negligible and re- 
mained similar to control evels after normoxemic 
reoxygenation. 
Antioxidant reserve capacity. Myocardial samples 
were analyzed for antioxidant reserve capacity in 
control piglets undergoing CPB without hypoxemia, 
at the end of the hypoxemic interval on CPB and 
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Fig, 4. Myocardial conjugated iene production during hypoxemia-reoxygenation on CPB. CPB: Piglets 
performed hyperoxemic bypass without hypoxemia; reoxygenation: piglets performed reoxygenation  
CPB at Po2 about 400 mm Hg or about 100 mm Hg after hypoxemia. *p < 0.05 vs CPB; ~'p < 0.05 vs Po2 
about 400 mm Hg. 
after the 30-minute post-CPB observation period in 
piglets undergoing both hyperoxemic and normox- 
emic reoxygenation on CPB. Hypoxemia per se 
reduced antioxidant reserve capacity, as 25% more 
malondialdehyde was produced in myocardium ex- 
posed to hypoxemia without reoxygenation than in 
the control myocardium. Hyperoxemic reoxygen- 
ation reduced antioxidant reserve capacity further, 
whereas normal antioxidant reserve capacity was 
retained after normoxemic reoxygenation (Fig. 6). 
Discussion 
This study of immature piglets subjected to the 
model of "compensated" hypoxemia on CPB docu- 
ments that (1) hyperoxemic CPB produces an oxy- 
gen-mediated myocardium injury characterized by 
lipid peroxidation, reduced endogenous antioxidant 
reserve capacity, membrane disruption (enzyme 
leak), and depressed myocardial performance, and 
(2) this iatrogenic damage is limited substantially by 
maintaining normoxemia during reoxygenation on 
CPB and during the subsequent observation period. 
These findings confirm the occurrence of an "unin- 
tended" surgical reoxygenation injury when cyanotic 
immature hearts are placed on conventional hyper- 
oxemic CPB and emphasize the potentially impor- 
tant role of normoxemic management during surgi- 
cal correction of defects causing cyanosis. 
Chronic clinical cyanosis is associated with meta- 
bolic adaptations 1' z that allow normal aerobic me- 
tabolism to persist in the resting state; myocardial 
oxygen consumption, glucose and free fatty acid 
uptake, and lactate extraction remain comparable 
with that in noncyanotic patients, 2 and there is no 
shift toward anaerobic distribution of the lactate 
dehydrogenase isoenzyme. 19Studies of mitochon- 
dria from chronically cyanotic patients how a 30% 
to 40% greater oxidative capability (state 3 respira- 
tory activity) than in the mitochondria of normox- 
emic myocardium. This enhanced respiratory capac- 
ity is sustained over several weeks of observation i
the incubation medium. 2° This finding may in part 
explain the capacity 1~o maintain aerobic metabolism 
under resting conditions in chronically cyanotic pa- 
tients despite low oxygen tension. This compensa- 
tory mechanism is expended readily with stress, as 
atrial pacing causes myocardial lactate production 
and inorganic phosphate, indicating a shift toward 
anaerobic metabolism, zl This metabolic shift may 
occur also in cyanotic patients during the stresses of 
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Fig. 5. Myocardial CK production during hypoxemia-reoxygenation on CPB. CPB: Piglets performed 
hyperoxemic bypass without hypoxemia; reoxygenation: piglets performed reoxygenation  CPB at Po 2 
about 400 mm Hg or about 100 mm Hg after hypoxemia. *p< 0.05 vs CPB; tp < 0.05 vs Po a about 400 
mm Hg. 
daily life, such as exercise, emotional upset, and 
tachycardia and become compounded during anoxic 
spells. 
Our in vivo model of hypoxemia on bypass was an 
acute preparation so that the aforementioned mito- 
chondrial adaptions were absent. The assurance of 
normal oxygen delivery by increasing perfusion flow 
rate and hematocrit level during hypoxemia avoided 
anaerobiosis and ensured acompensated state of in 
vivo hypoxemia that may be relevant to the chroni- 
cally cyanotic ondition. 
Susceptibility of cyanotic myocardium to oxidant 
stress. Antioxidant reserve capacity was assessed by 
determining the extent of in vitro peroxidation of 
incubated myocytes exposed to the oxidant -butyl- 
hydroperoxide. This measurement reflects the ca- 
pacity of endogenous antioxidant enzymes (e.g., 
glutathione peroxidase) tolimit -OH-initiated chain- 
reaction propagation of lipid peroxidation. The ob- 
served fall in antioxidant reserve capacity during 
hypoxemia is consistent with clinical reports of 
endogenous antioxidant depletion in cyanotic myo- 
cardium 3 (i.e., superoxide dismutase, catalase, and 
glutathione peroxidase) that occurs despite meta- 
bolic adaptations. There is a strong correlation 
between Po 2 antioxidant enzyme levels, and suscep- 
tibility to oxygen-mediated damage in myocytes 
cultured from cyanotic patients. 22These clinical and 
experimental findings suggest that endogenous an- 
tioxidant defense mechanisms are weakened by hy- 
poxemia, therefore rendering the cyanotic myocar- 
dium more susceptible to subsequent intraoperative 
stress on reoxygenation a d during and after tem- 
porary surgical ischemia. 
These inferences are confirmed by a recent clini- 
cal report 6 showing that cyanotic hearts are more 
vulnerable than noncyanotic hearts to ischemia/ 
reperfusion damage despite comparable blood car- 
dioplegic protection and shorter ischemic times. The 
clinical findings of accelerated adenosine triphos- 
phate (ATP) depletion, lactate accumulation, and 
myocardial depression provide confirmation of ex- 
perimental studies 1°-12 showing that chronic cyano- 
sis predisposes the myocardium to energy deple- 
tion 1° and postischemic contractile dysfunctionJ 1' 12 
These reports did not, however, consider the possi- 
bility that reoxygenation-induced damage before su- 
perimposed ischemia contributed to the final bio- 
chemical and functional findings. The present 
study intentionally excluded any ischemia to focus 
on the potential adverse ffects of reinstitution of 
molecular oxygen to hypoxemic myocardium with 
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Fig. 6. Antioxidant reserve capacity: effects of Po2 during reoxygenation. Data are expressed asmalon- 
dialdehyde production i the myocardium incubated with 4.0 mmol t-butylhydroperoxide. Dotted bar shows 
range of mean values _+ SE from control piglets without CPB. CPB: Piglets undergoing hyperoxemic bypass 
without hypoxemia; reoxygenation: piglets undergoing reoxygenation on CPB at Po 2 about 400 mm Hg or 
about 100 mm Hg after hypoxemia. *p< 0.05 vs CPB; ?p < 0.05 vs Po2 about 400 mm Hg. 
depleted endogenous antioxidant defense mecha- 
nisms. 
Surgical reoxygenation i jury. This concept of 
surgical reoxygenation injury inferred by our exper- 
imental observations after hyperoxemic CPB is sup- 
ported by clinical evidence of lipid peroxidation and 
reduced antioxidants in preischemic biopsy samples 
of the right ventricle from cyanotic patients placed 
on CPB, 5 for correction of tetralogy of Fallot, and 
myocardial dysfunction after reoxygenation by ex- 
traeorporeal membrane oxygenation 7 in infants 
with pulmonary disorders causing cyanosis. Normal 
lactate metabolism persisted uring "compensated 
hypoxemia" and normoxemic reoxygenation, but 
lactate production followed hyperoxemic reoxygen- 
ation. This metabolic shift toward anaerobic energy 
production may be related to mitoehondrial dys- 
function caused possibly by reoxygenation-induced 
mitochondrial calcium loadingY Our previous tud- 
ies confirmed the inverse relationship between mi- 
tochondrial calcium and state 3 respiratory activity 
in the ischemic/reperfusion model, 24 and similar 
alterations may occur after reoxygenation despite 
the compensatory increase in mitoehondrial ctivity 
during cyanosis. 2° The role of reactive oxygen spe- 
cies in ischemic/reperfusion injury seems estab- 
lished, and our studies uggest that they may also 
play a major role in the pathogenesis of surgical 
reoxygenation injury. These data document an im- 
balance between antioxidant reserve capacity during 
hypoxemia nd enhanced free radical generation 
after reoxygenation. 
Our studies are purely observational nd do not 
define the relative contributions of the multiple 
sources of oxygen free radicals including the xan- 
thine oxidase systemy activated neutrophilsy leak- 
age of electrons from electron transport system 
within the mitochondria, 26 and from the cyclooxyge- 
nase pathway of arachidonic acid metabolism 27 and 
catecholamine metabolism. 28 We suspect, however, 
that some potential sources of free radical genera- 
tion operative during reperfusion may not necessar- 
ily play an important role in the pathogenesis of
reoxygenation injury after compensated hypoxemia. 
In part the initial burst of free radicals after reper- 
fusion results from the accumulation a d availability 
of neutrophils for activation during stagnant flow 
and byproducts of ATP degradation (i.e., hypoxan- 
thine) that can cause an immediate burst of oxygen 
radicals on reoxygenation with consequent lipid 
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peroxidation and alteration in electron carriers in 
mitochondria. The high flow condition during in 
vivo hypoxemia may limit the margination of neu- 
trophils and buildup of byproducts of ATP degrada- 
tion. 
In contrast, under physiologic onditions, normal 
intact mitochondria nd sarcoplasmic reticulum 
produce 02- and H20 2. This production is en- 
hanced by hyperoxemia 26 in a Po2-dependent way, 
and these oxygen free radicals are counteracted 
by endogenous antioxidants. Hyperoxemia sharply 
elevates the amount of oxygen dissolved in the 
membrane lipid matrix, thereby enhancing the pos- 
sibility of 02 interaction with reduced electron 
carriers and accentuating free radical produc- 
tion.26, 29-31 In addition, CPB per se causes comple- 
ment-mediated activation of polymorphonuclear 
neutrophils (PMNs) leading to free radical produc- 
tion. 32 This sequence may proceed in a self-propa- 
gating manner, because PMN-derived free radicals 
can trigger the secretion of chemotactic substances 
that further ecruit and activate PMNs to produce 
more free radicalsY Consequently, initiation of 
hyperoxemic CPB may induce sufficient free radical 
generation to overwhelm reduced endogenous anti- 
oxidant defense system caused by hypoxemia nd 
produce the signs of lipid peroxidation (conjugated 
dienes and subsequent cellular disruption) and CK 
enzyme release reported herein. We interpret he 
initial delay and subsequent progressive increase in 
CK and conjugated iene levels to reflect ongoing 
reoxygenation damage that may differ from the 
immediate oxidative reaction that follows reperfu- 
sion. Perhaps the systemic nflammatory esponse to 
CPB may play an important role in the pathogenesis 
of damage, because gradual increases in neutro- 
phil 34 elastase and myeloperoxidase activity, 34 ana- 
phylatoxins C3a and C5a, 32'34 and H202 produc- 
tion 32 occur as the interval of CPB is prolonged. 
Implications. Maintaining normoxemia rather 
than hyperoxemia substantially reduced oxidant 
damage (lipid peroxidation, enzyme leak, and deple- 
tion of antioxidant reserve capacity) while retaining 
normal actate metabolism and decreasing the ex- 
tent of myocardial stunning. These benefits coincide 
with the Po2-dependent ature of reoxygenation 
injury, because free radical production in in vitro 
bioassay systems 14 and myocardial injury after 
reoxygenation of isolated heart preparations 3s'36 
are proportionate to oxygen tension. In clinical 
practice hyperoxemic bypass is performed routinely 
but is likely never needed, because Po 2 > 100 to 150 
mm Hg confers only negligible increase in 0 2 con- 
tent. The avoidance of hyperoxemia during reoxy- 
genation in cyanotic infants to reduce injury may in 
a sense be comparable with restricting inspired Fio2 
in newborn infants to avoid retrolental hyperpla- 
sia. 37 Confirmation by others of the importance of 
normoxemic management may allow such treatment 
to be used to surgical advantage in the treatment of
cyanotic infants. 
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